Latest News by Industry
Entrada Therapeutics, Inc. [TRDA] has reported fiscal Q1 loss of $6.70 million.
On a per-share basis, the DE based company said its diluted earnings are $0.21.
The Pharmaceutical Preparations firm posted revenue of $25.30 million in this period.